January 2025 - Page 16 of 75

84 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert

New Delhi: In line with the ‘Not of Standard Quality’ data provided by states, the apex drug regulatory body, the Central Drug Standard Control Organisation (CDSCO), in its latest drug safety alert, has flagged 84 medicine batches for failing to qualify for a random sample test for December 2024.

The list of drugs declared not of standard quality includes Cefpodoxime Tablets IP 200 mg (Jan Aushadhi) manufactured by Bharat Parenterals, CEFIXIME AND LACTIC ACID BACILLUS TABLETS (CFI200) manufactured by Swiss Biotech Parentrals, Pantacea 40 Tablets and Pantoprazole Gastro Resistant Tablets IP 40 mg manufactured by Windlas Biotech, Metoprolol Succinate Prolonged Release Tablets IP manufactured by Unicure India, Losartan Potassium Tablets IP 50 mg manufactured by Hindusthan Antibiotics, Ondansetron Injection IP-2ml manufactured by Skymap Pharamceuticals and others.

Furthermore, the list includes Gabacure Gel and Snikuf 4 manufactured by Akums Drugs and Pharmaceuticals, CIPRODAC 500 (Ciprofloxacin Tablets IP 500mg) manufactured by Cadila Pharmaceuticals, METFORMIN HYDROCHLORIDE TABLETS IP (OKAMET500) manufactured by Cipla.

Many factors contributed to the drug samples’ failure in the test, such as non-compliance with the IP requirements for the particular drug, failure of the dissolution test, pH, and some assays of the drug test, among others.

In addition to the above, the alert mentioned that the Not of Standard Quality (NSQ) data was received as per Format and in EXCEL SHEET from State Drugs Licensing Authorities of Jammu Kashmir, Tamil Nadu, Himachal Pradesh, Puducherry, Telangana, Thiruvananthapuram (Kerala), Tripura, Ladakh, Karnataka.

Further, it added that NSQ data was received from West Bengal, Goa, as NIL. However, data was not received as per format in Excel Sheet from Assam (PDF Format), Rajasthan (PDF Format), Jharkhand (PDF Format), and Mizoram (PDF Format) for the Month of December 2024 as per DCG(I) Circular dated 09.02.2024.

Also Read:Drug Alert: CDSCO Flags 51 Formulations As Not Of Standard Quality

In addition, the alert stated that State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Bihar, Chhattisgarh, Gujarat, Haryana, Manipur, Meghalaya, Nagaland, Odisha, Punjab, Sikkim, Delhi, Uttarakhand, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of December, 2024 as per DCG(I) Circular dated 09.02.2024.

NOT OF STANDARD QUALITY ALERT FOR THE MONTH OF DECEMBER– 2024

B. State Laboratories
S.No	Product/Drug Name	Batch No.	Manufact uring Date	Expiry Date	Manufactured By	NSQ Result	Reported by State Laboratory
1.	Divalproex Extended Release Tablets IP (JKMSCL Hospital Supply not for sale)	2406031	06/2024	05/2026	Biodeal Pharmaceuticals Ltd Vill Saini MajraNalagarhRopar Road , Nalagarh – 174101 , Distt. Solan (H.P) India	Uniformity of Weights	DTL Srinagar (J&K) & MDTL Kathua (J&K)
2.	Divalproex Extended Release Tablets IP (JKMSCL Hospital Supply not for sale)	2407185	07/2024	06/2026	Biodeal Pharmaceuticals Ltd Vill Saini MajraNalagarhRopar Road , Nalagarh – 174101 , Distt. Solan (H.P) India	Uniformity of Weights	DTL Srinagar (J&K)
3.	Cefpodoxime Tablets IP 200 mg (Jan Aushadhi)	CT3096	09/2023	08/2025	Bharat Parenterals Ltd Survey No. 144-A, Jarod-SamlayaRoad ,Vill. Haripura , Tal. Savil Dist. Vadodara – 391520 Gujarat India	Assay of Cefpodoxime	CFDL Jammu (J&K)
4.	DEXTROMETH ORPHAN HYDROBROMI DE	AST- 23303	Aug-23	Jul-25	M/s.AASSK Pharmaceuticals Pvt. Ltd. Plot No.9, S.no 243/2,	On visual inspection dark spots are found on tablet surface.Cappingand	Puducherry

	PHENYLEPHRI NE HYDROCHLOR IDE & CHLORPHENIR AMINE MALEATE TABLETS (Expal)				Dr.AmbedhkarStreet, Kozhumanivakkam, Mangadu, Chennai- 600 122	lamination defects are found. Some tablets were brittle on opening from the strip – NSQ
5.	BETAHISTINE DIHYDROCHL ORIDE TABLETS IP (CGHEST-8)	CT242502 84B	May-24	Apr-26	M/s CMG BIOTECH PVT. LTS (Unit-II), Plot No. 58, PhaseIII, Industrial Area, Sansarpur Terrace, Tehsil Jaswan, Distt.Kangra, HP- 176501	On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discolouration	Puducherry
6.	METFORMIN HYDROCHLOR IDE TABLETS IP (OKAMET- 500)	4O30069	Feb-24	Jan-27	M/s.Cipla Ltd., Ropar Road, Nalagarh, Dist. Solan (H.P)-174 101	Does not comply with respect to the Assay as per IP specification	Puducherry
7.	PANTOPRAZO LE GASTRO- RESISTANT TABLETS IP 40mg (Pentowok)	WAM2401 1	May-24	Apr-26	M/s Admed Pharma Pvt Ltd., Plot No 87, HPSIDC, Industrial Area, Badddi, DisttSolan HP- 173 205	Does not comply with respect to the Disintegration test as per IP specification	Puducherry
8.	ZINC SULPHATE DISPERSIBLE TABLETS IP	TH241106	Aug-24	Jul-26	M/s Orchid MedlifePvt. ltd., (WHO GMP & GLP certified company)	On the received sample chipping and rough surface defects were	Puducherry

	20mg (CARE ZINC)				Vill.Kaundi,P.O Thane, Khasra No. 646/513, Tehsil Baddi, Dist. Solan (H.P)- 173 205.	observed, which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(V) and (VII) respectively
9.	CEFIXIME AND LACTIC ACID BACILLUS TABLETS (CFI- 200)	T925	Sep-23	Aug-25	M/s. Swiss Biotech Parentrals., Kewat No. 1138,VPO – Kachhwa, Karnal- 132001 (Haryana)	On the received sample presence of spots/discoloration observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration	Puducherry
10.	METFORMIN TABLETS IP 500 mg (GLYCIPHAGE)	G0374057	Jun-24	May-27	M/s.Franco-Indian Pharmaceuticals Pvt Ltd, 20, DR. E. Moses Road, Mumbai-400 011	Does not comply with respect to the Assay as per IP specification	Puducherry
11.	Ceaxil -500 Tablets, Cefuroxime Axetil Tablets IP	BT-227375	01/2024.	12/2025.	Dr Edwin Medilabs Pvt Ltd Plot No.B-29, Industrial Area, Focal Point, Chanalon, Kurali, SAS Nagar- 140103(Pb) PUNJAB	White coloured, elongated, biconvex tablets with score on one side, and plain on other side, 10 out of 50 tablets have brown- coloured spots on	State Lab, Drugs Control Laboratory, Telangana.

						the entire surface. Hence, the tablets failed the test for Description of tablets.
12.	Jakclav-625 Tablets, Amoxicillin and Potassium Clavulanate Tablets	BPT-3002	02/2024.	01/2026.	Geenac Pharma Plot No: 582, Raipur, Bhagwanpur, Roorkee, Uttarakhand-247667. UTTARAKHAND . Mrkt By: WellnowHelathcare, Kanal Industrial Estate, Road No. 6, Borivali East, Mumbai-400066.	The sample Does not meet the Specifications wrt. Identification test – Negative, Assay- Nil As per IP u/s. 17B of Drugs and Cosmetics Act 1940. the Sample deemed to be SPURIOUS and Misbranded.	State Lab, Drugs Control Laboratory, Telangana.
13.	Jikcef-LB Tablets, Cefixime and Lactic Acid Bacillus Tablets	BPT-3005	02/2024.	01/2026.	GeenacPharma Plot No: 582, Raipur, Bhagwanpur, Roorkee, Uttarakhand-247667. UTTARAKHAND . Mrkt By: WellnowHelathcare, Kanal Industrial Estate, Road No. 6, BorivaliEast, Mumbai- 400066.	The sample does not meets the Specifications with respect to Identification test-Nil Assay-Nil As per STP u/s. 17B of Drugs and Cosmetics Act 1940. The Sample deemed to be SPURIOUS.	State Lab, Drugs Control Laboratory, Telangana.
14.	Jikcf-AZ Tablets, Cefixime and Azitromycin Tablets	BPT-3001	02/2024.	01/2026.	Geenac Pharma Plot No: 582, Raipur, Bhagwanpur, Roorkee, Uttarakhand-247667. UTTARAKHAND .	The sample does not meets the Specifications with respect to Identification test-Nil Assay-Nil	State Lab, Drugs Control Laboratory, Telangana.

					Mrkt By: WellnowHelath care, Kanal Industrial Estate, Road No. 6, Borivali East, Mumbai-400066.	As per STP u/s. 17B of Drugs and Cosmetics Act 1940. The Sample deemed to be SPURIOUS.
15.	Vithrocin Suspension, Azithromycin Oral Suspension	AZ/L/01/40 09	08/2024.	07/2026.	Vital Therapeutics & Formulations Pvt.Ltd . Plot No. 47b/2, Phase-1, IDA, Cherlapally, Medchal- Malkajgiri District – 500051, Telangana, INDIA. Telangana	As sample failed with respect to test in pH as per IP further product is MISBRANDED	State Lab, Drugs Control Laboratory, Telangana.
16.	Pantacea 40 Tablets and Pantoprazole Gastro Resistant Tablets IP 40mg	PNTC3007	11/2023.	10/2025.	Windlas Biotech Limited Plant-2, Khasra No. 141 to 143 & 145, MohabewalaIndl.area, Dehradun – 248110 (U.K.) UTTARAKHAND Mrkt By: Panacea Life Sciences Limited, DCM Building, OffceNo.5, Seventh floor, 16 Barakhamba Road, Connauught place, New Delhi- 110001.	The sample Does not complies in respect of Dissolution Test as per IP.	State Lab, Drugs Control Laboratory, Telangana.
17.	Pantoprazole Sodium Tabletes IP 40mg	P01824	08/2024.	07/2026.	Spansules formulation India Pvt Ltd Sy. No. 172, Plot.No.154/A4 IDA Bollaram (V), Jinnaram (M), Sangareddy (D), Hyderabad	The sample Does not comply in respect of Dissolution Test as per IP.	State Lab, Drugs Control Laboratory, Telangana.

					Telangana
18.	Metoprolol Succinate Prolonged Release Tablets IP	URDT0654	03/23	02/25	Unicure India Ltd., Plot No. 46(B)/49B Village Raipur, Bhagwanpur ,RoorkeeDist, Haridwar, Uttarakhand	It fails the test ‘Assay’ as per IP standards [Amendment List – 05 to IP 2022]	Drugs Testing Laboratory Thiruvananthapuram
19.	Metoprolol Succinate Prolonged Release Tablets IP	URDT0653	03/23	02/25	Unicure India Ltd., Plot No. 46(B)/49B Village Raipur, Bhagwanpur ,RoorkeeDist, Haridwar, Uttarakhand	It fails the test ‘Assay’ as per IP standards [Amendment List – 05 to IP 2022]	Drugs Testing Laboratory Thiruvananthapuram
20.	Metoprolol Succinate Prolonged Release Tablets IP	URDT0652	03/23	02/25	Unicure India Ltd., Plot No. 46(B)/49B Village Raipur, Bhagwanpur ,RoorkeeDist, Haridwar, Uttarakhand	It fails the test ‘Assay’ as per IP standards [Amendment List – 05 to IP 2022]	Drugs Testing Laboratory Thiruvananthapuram
21.	Losartan Potassium Tablets IP 50 mg	HLOA09	11/23	10/25	Hindusthan Antibiotics Ltd, At 11, W.E.A, Faridabad – 121 001, Haryana	It fails the test ‘Dissolution’ as per IP as specified in the Laboratory Protocol	Drugs Testing Laboratory Thiruvananthapuram
22.	Amoxymoon CV-625 [Amoxycillin and Potassium Clavulanate Tablets IP]	VT 241704	10/24	03/26	VADSP Pharmaceuticals, Plot No.124, EPIP, Indl.Area, Phase-1, Jharmajri, Baddi (H.P) 174 103	It fails the tests ‘Assay’ and ‘Dissolution’ for Clavulanic Acid as per IP, as specified in the Laboratory Protocol .	Drugs Testing Laboratory Thiruvananthapuram
23.	Balarishtam	107	09/24	10 Yrs. Form packing	Alappat Pharma, Kollam-691503	It fails the test Total Solids and Specific Gravity as per API	Drugs Testing Laboratory Thiruvananthapuram
24.	Metformin	D2164/24-			Kerala Medical	It fails the test	Drugs Testing

	Hydrochloride Sustained Release Tab IP 500 mg	25			Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram- 14	microbial contamination in Non-sterile products and Descriptive part for tablets as per IP	Laboratory Thiruvananthapuram
25.	Paracetamol Tab IP 500 mg.	D2370/24- 25			Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram- 14	It fails the test ‘Dissolution’ as per IP	Drugs Testing Laboratory Thiruvananthapuram
26.	CIPRODAC 500 (Ciprofloxacin Tablets IP 500mg)	AN24014	Jan-24	Dec-26	Cadila Pharmaceuticals Limited, 1389, Dholka – 382225, Dist: Ahmedabad, At: A-1, Ratan Industrial Area, Harsuliya, Jaipur. C/o. M/S. Anon Pharmaceutical, Jaipur. Mfg. Lic. No.: RAJ/JPR/2718.	The Sample does not conform to standard in respect of the test “Dissolution” performed	State Drugs Testing Laboratory, Agartala, Tripura.
27.	Metoheal XL 25 (Metoprolol Succinate Extended release Tablets U.S.P)	T24D800A	D/M: Apr/2024	D/E: Mar/2026	M/s. Bajaj Formulation, Khasra No.161, Village- LakeshwaryBhagwan pur, RoorkeeDistt: Haridwar (UK)	Test for Dissolution” & content of Metoprolol Succinate in the Assay	Karnataka
28.	Panik-D Tablets (Pantoprazole Sodium &Domperidone Tablets)	KPT24K08 A	D/M:02/2 024	D/E:01/202 6	M/s. Kaizen Pharmaceuticals, Vill. Katha, Baddi-173205 Distt. Solan (H.P)	test for Disintegration	Karnataka
29.	Fercobate-XT Suspension (Ferrous Ascorbate& Folic acid Suspension)	240603	D/M: Jun/2024	D/E: Nov/2025	M/s. ShinestarPharma, Begapali Road, SIPOCT-1, Hosur- 635126 (T.N)	Folic Acid in the Assay and Misbranded	Karnataka

30.	CefpodoximePr oxetil Dispersible Tablets (Qupod- 200 Tablets)	KCT- 403002	D/M:03/2 024	D/E:02/202 6	M/s. Knox Life Sciences, Vill. Gullarwala, Sai Road, Baddi, Distt. Solan (H.P)	Test for Uniformity of Dispersion	Karnataka
31.	Calcium Carbonate & Vitamin D3 Tablets (Calcovit D3 Tablets)	MWT2311 80	D/M: Jan/2024	D/E: Dec/2025	M/s. MedworPharma, 140 EPIP, Phase-II, Thana, Baddi 173205	Test for Dissolution for Calcium, Assay for Vitamin D3” and with respect to “Description	Karnataka
32.	Ranitidine Hydrochloride Injection I.P	AV3082	D/M: 02/2023	D/E: 01/2025	M/s. Alpa Laboratories Ltd., 33/2 A.B. Road, Pigdamber-453 446, Indore (M.P)	Test for Sterility	Karnataka
33.	Cipex-500 (Ciprofloxacin Tabets I.P)	MUTAD23 01	D/M: Jun/2023	D/E: May/2026	M/s. Maxtar Bio- Genics, K.No.705, Nalagarh Road, MalkuMajra, Baddi- 173205 (H.P)	Test for Dissolution only	Karnataka
34.	Terbicharge 250 mg (TerbinafineHyd rochloride Tablets IP)	NT-4303	D/M: 06/2023	D/E: 05/2025	M/s. Neptune Life Sciences Pvt. Ltd., 100-B, EPIP, Phase- II, Thana, Baddi- 173205 (H.P)	Test for Dissolution only	Karnataka
35.	Levocetirizin Hydrochloride &Montelukast Sodium Tablets IP (Montefirst- LC)	2405097	D/M: May/2024	D/E: Apr/2026	M/s. Aban Pharmaceuticals, Plot No. 1018, Kerala, G.I.D.C., Bavla, Dist. Ahmedabad-382220	Test for Dissolution of Levocetirizine Hydrochloride and Montelukast	Karnataka
36.	Paracetamol Tablets IP 650 mg	PCT24135	D/M: 06/2024	D/E: 05/2026	M/s. VivekPharmachem (India) Ltd., NH-8, Chimanpura, Amer, Jaipur-303102	Test for Dissolution	Karnataka
37.	Aluminium,	C21A1330	D/M:	D/E:	M/s. Concept	Description only	Karnataka

	Magnesium &Simethicone Oral Suspension I.P	03	06/2023	05/2026	Pharmaceuticals Ltd., A-28/3, MIDC, Chikalthana, Aurangabad-431006
38.	ITRACHARGE 200 (Itraconazole Capsules BP)	NC-0805	D/M: 06/2023	D/E: 05/2025	M/s. Neptune Life Sciences Pvt. Ltd., 100-B, EPIP, Phase- II, Thana, Baddi- 173205 (H.P)	Dissolution Test only	Karnataka
39.	Ondansetron Injection IP-2ml	A24AM130	04/2024	03/2026	Skymap Pharamceuticals Pvt. Ltd, B-2 Dev Bhoomi Industrial Estate, Puhana Iqbalpur Road, Roorkee – 247 667	sample does not conform to requirement for assay and related substances	King Institute of Preventive Medicine & Research, Guindy, Chennai-32
40.	Cipladine Multipurpose Antiseptic Skin Ointment	CH040103	03/2024	02/2026	HSN International, At Plot No.54-55, Sector 6A, I.I.E, Sidcul, Haridwar, Uttarakhand,249403.	Sample does not conform to USP specification for povidone-Iodine Ointment with respect to content of available Iodine in povidone Iodine.	Drugs Testing Laboratory, Chennai – 6
41.	Povidone- Iodine Ointment USP	VG24025	04/2024	03/2026	Microwin Labs PVt Ltd, Plot No.363, Industrial Focal Point, Phase-9, Mohali- 160062.	Sample does not conform to USP Spcification for povidine-IODINE Ointment with respect to the content of Avaible Iodine in povidone Iodine.	Drugs Testing Laboratory, Madurai – 19.
42.	Atorvastatin Calcium Tablets IP 10mg	HTN414D	04/2024	03/2026	Himalaya Meditek Pvt. Ltd, Plot No. 35 & 36, Pharmacity, Selaqui, Industrial Area, Dehradun – 248	Sample does not conform to IP Specification for Atorvastatin Calcium Tablets	Drugs Testing Laboratory, Chennai – 6

					197	with respect to Dissolution
43.	Atorvastatin Calcium Tablets IP 10mg	HTN405D	04/2024	03/2026	Himalaya Meditek Pvt. Ltd, Plot No. 35 & 36, Pharmacity, Selaqui, Industrial Area, Dehradun – 248 197	Sample does not conform to IP Specification for Atorvastatin Calcium Tablets with respect to Dissolution	Drugs Testing Laboratory, Chennai – 6
44.	Ciprofloxacin Hydrochloride Tablets IP 500mg	HTN1126L	11/2023	10/2025	Himalaya Meditek Pvt. Ltd, Plot No. 35 & 36, Pharmacity, Selaqui, Industrial Area, Dehradun – 248 197	Sample does not conform to IP specification for ciprofloxacin tablets with respect to Dissolution	Drugs Testing Laboratory, Chennai – 6
45.	Amlod-At	DT240289	02/2024	01/2026	Daeiou Pharmaceutical (P) Ltd, R.S.No.158, Puducherry – Villupuram Main Road, Villianur, Puducherry, 605110.	Sample does not conform to IP Specification for Amlodipine and Atenolol Tablets with respect to Dissolution for Amlodipine and to the Content of Amlodipine in Amlodipine in Amlidipine Besylate.	Drugs Testing Laboratory, Chennai – 6
46.	Glimepiride Tablets IP 1mg	PGG24- 002	06/2024	05/2026	Pondchy Pharmaceuticals, R.S.No.218/4, 218/5, Odiaampet, Manaveli Road, Villianur Commune, Puducherry, 605110.	Sample does not conform to IP specification for Glimepiride Tablets with respect to Dissolution.	Drugs Testing Laboratory, Chennai – 6
47.	Snikuf 4	RZAB01	05/2023	04/2025	Akums Drugs & Pharmaceuticals Ltd, 22, Sector-6A, I.I.E, Sidcul. Ranipur,	Sample does not conform to label claim with respect to the content of	Drugs Testing Laboratory, Chennai – 6

					Haridwar-249403, Uttrakhand.	Terbutaline Sulphate.
48.	Trubery LS	Z-23388	09/2023	08/2025	CSD Lifesciences, Village Malkumajra, Morepen Road, Baddi, Distt, Solan, (H.P). 173205.	Sample does not conform to Label with respect to the content of Levosalbutamol in Levosalbutamol sulphate.	Drugs Testing Laboratory, Chennai – 6
49.	Sucrazum-O Suspension	ALL-899	08/2023	07/2025	Access Life Science, Khasra No.551/3, Village Taksal, Parwanoo, Distt, Solan (HP), 173220.	Sample does not conform to Label claim with respect to the content of Oxetacaine.	Drugs Testing Laboratory, Chennai – 6
50.	Rosuvastatin, Aspirin & Clopidogrel Capsules (20mg/75mg/75 mg)	MC240184	02/2024	01/2026	Mascot Health Series Pvt Ltd., Plot No. 79, 80 Sec-6A, IIE, Sidcul, Haridwar- 249 403	Sample does not conform to Label claim with respect to the content of Aspirin and to Schedule V of Drugs and Cosmetics Act, with respect to free Salicylic Acid.	Drugs Testing Laboratory, Chennai – 6
51.	Metoclopramide HCL Injection I.P-2ml	24DQC64	03/2024	02/2026	SVP Life Sciences, C/10-1, Sara Industrial Estate, Selaqui, Dehradun	sample does not conform to the requirement for Assay of Metoclopramide	King Institute of Preventive Medicine & Research, Guindy, Chennai-32
52.	Metoclopramide HCL Injection I.P-2ml	HLI405D	04/2024	03/2026	Himalaya Meditek Pvt. Ltd, Plot No. 35 & 36, Pharmacity, Selaqui, Industrial Area, Dehradun – 248 197	sample does not conform to the requirement for Assay of Metoclopramide	King Institute of Preventive Medicine & Research, Guindy, Chennai-32
53.	Amitriptyline Tablets IP 25mg	TA24159	04/2024	03/2026	Saintlife Pharmaceuticals Ltd, 323, Central Hope	Sample does not conform to IP specification for	Drugs Testing Laboratory, Chennai – 6

					Town, Industrial Area, Selaqui, Dehradun – 248 011, Uttarakhand, India	tablets with respect to Definition.
54.	Megapure-TZ IU suspension	23L-162	09/2023	08/2025	Prispag Pharma, Roomi, Jagraon – 142030.	Sample does not conform to label claim with respect to the content of Ciprofloxacin in Ciprofloxacin Hydrochloride and Tinidazole.	Drugs Testing Laboratory, Chennai – 6
55.	Octenidine Dihydrochlordie Gel	PPKAC84	05/2023	04/2026	Pure & Cure Healthcare Pvt Ltd, (A Subsidiary of Akums Drugs & Pharmaceuticals Ltd,) Plot No.26A,27-30, Sector – 8A,IIE, Sidcul, Haridwar- 249403. Uttarakhand.	Sample does not conform to label claim with respect to the content of Octenidine Dihydrochloride.	Drugs Testing Laboratory, Madurai – 19.
56.	Dexamethasone Tablets IP 0.5mg	TA24036	01/2024	12/2025	Saintlife Pharmaceuticals Ltd, 323, Central Hope Town, Industrial Area, Selaqui, Dehradun – 248 011, Uttarakhand, India	Sample does not conform to IP Specification for Dexamethasone Tablets with respect to the content of Dexamethasone.	Drugs Testing Laboratory, Chennai – 6
57.	Dexamethasone Tablets IP 0.5mg	TA24035	01/2024	12/2025	Saintlife Pharmaceuticals Ltd, 323, Central Hope Town, Industrial Area, Selaqui, Dehradun – 248 011, Uttarakhand, India	Sample does not conform to IP Specification for Dexamethasone Tablets with respect to the content of Dexamthasone.	Drugs Testing Laboratory, Chennai – 6
58.	Peedon	P2409	05/2024	04/2026	Sharing formulations Pvt Ltd, Plot No.41,G.I.D.C,	Sample does not conform to label claim with respect	Drugs Testing Laboratory, Chennai – 6

					Waghodia, Vadodara. 391760.	to the content of Available Iodine in Povidone-Iodine.
59.	Esilac Soluion	ZBL-1154	12/2023	11/2025	Zoic Biotech Pvt Ltd, Plot No.C-15, Focal Point, Ind. Area, Chanalon, Mohali, (Punjab), 140103.	Sample does not conform to USP Specification for Lactulose Solution with respect to the Content of Lactulose in Lactulose Concentrate.	Drugs Testing Laboratory, Chennai – 6
60.	Amoxycillin Dispersible Tablets IP 125 mg	PGA24- 002	03/2024	02/2026	Pondchy Pharmaceuticals, R.S.No.218/4, 218/5, Odiaampet, Manaveli Road, Villianur Commune, Puducherry, 605110.	Sample does not conform to IP Specification for Dispersible Tablets with respect to uniformity of Dispersion and Disintegration	Drugs Testing Laboratory, Chennai – 6
61.	Orsiclop-A75	NTT24103 6	03/2024	02/2026	Nanoceut Therapeutics Pvt Ltd, R.S.No. 104/19A, E.V.R.Street, Sedarapet, Puducherry, 605111	Sample does not conform to IP specification for Clopidogrel and Aspirin Tablets with respect to Dissolution ( Clopidogrel and Aspirin), Free Salicylic Acid (Related substance for Aspirin) and to the content of ASpirin	Drugs Testing Laboratory, Chennai – 6
62.	Iron Sucrose Injection USP- 5ML	PGY23118	08/2023	07/2025	Affy Parenterals, Vill. Gullerwala, P.O. Baddi, Distt. Solan – 173 205 (H.P)	Sample does not conform to requirement for assay for iron.	King Institute of Preventive Medicine & Research, Guindy, Chennai-32

63.	Justkof-LS	UF267408 2F	01/2024	12/2025	Ultra Drugs Formultations Pvt Ltd, Plot No.338/278, Vill. Manakpur, Lodhimajra, Tehsil- Baddi, Distt. Solan (HP)-173205.	sample does not conform to Label claim with respect to the content of Ambroxol Hydrochloride.	Drugs Testing Laboratory, Madurai – 19.
64.	Gabacure Gel	HUAA46	06/2024	11/2025	Akums Druges & Pharmaceuticals Ltd. 47,48,Sector-6A, I.I.E., SIDCUL,, Haridwar-249 403, Uttarakhand.	Sample does not conform to Label claim with respect to the content of Gobapentin.	Drugs Testing Laboratory, Madurai – 19.
65.	Dexamethasone Injection IP-2ml	FDDTI-004	02/2024	01/2026	Laborate Pharmaceuticals India Ltd, 51 Indl. Area, Paonta Sahib (HP).	Sample does not conform to requirement for Assay.	King Institute of Preventive Medicine & Research, Guindy, Chennai-32
66.	Ondansetron Tablets IP 4 mg	320D2401	04/2024	03/2026	SSM Formulations Private Limited, Survey No. 11/1, Mouza Ashti (Rith), Hinganghar (M.H), 442301	Sample does not conform to IP Specification for Ondansetron Tablets with respect to Dissolution.	Drugs Testing Laboratory, Chennai – 6
67.	O Mak-200	VMWT240 7	06/2024	03/2026	Vertex Pharma Chemicals, Plot No.60-A,61-A, PIPDIC Electronic Park, Tirubhuvanai, Puducheryy-605107.	Sample does not conform to IP Specification of Ofloxacin Tablets with respect to the content of Ofloxacin.	Drugs Testing Laboratory, Madurai – 19.
68.	Retrazith-250	WT3927F	03/2024	02/2026	Saphnix Life Sciences, Village- Barotiwala, Paonta Sahib,Distt, Siramour, Himachal Pradesh- 173025	Sample does not conform to IP specification for Azithromycin Tablets with respect to Dissolution and to the Content of Anhydrous	Drugs Testing Laboratory, Chennai – 6

						Azithromycin Dihydrate.
69.	Surgi Spirit	SS-084032	08/2024	07/2026	Transflex, Hawahar Nagar, Ranipur (C.G),492001.	Sample does not conform IP Specifciation for Surgical Spirit with respect to weight per ml.	Drugs Testing Laboratory, Chennai – 6
70.	Brokuf-DM	CBL- 0024/24	02/2024	01/2026	C.B.Healthcare, Village Messa Tibba, Tehsil Nalagarh, Distt, Solan (H.P),174101.	Sample does not conform to Label claim with respect to the content of phenylephrine Hydrochloride.	Drugs Testing Laboratory, Chennai – 6
71.	Tamcof-Ls Syrup	AGL23022 1C	03/2024	02/2026	Asterisk Healthcare, V.P.O Bathri, Thesil Haroli, Distt. Una (H.P),174301.	Sample does not conform to Label claim with respect to the content of Ambroxol Hydrochloride	Drugs Testing Laboratory, Chennai – 6
72.	Cadcof-Lx Syrup	DLS2378	06/2024	05/2026	Dhwanilife Care Pvt Ltd, Plot No.C-20/2, (C-39) & C-20/3, (C- 40), Arvind Mega Parek, Village- Chachravadi Vasna, Ahmedabad, Gujarat- 382213.	Sample does not conform to Label Claim with respect to the content of Levosalbutamol in Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin.	Drugs Testing Laboratory, Chennai – 6
73.	Co-Trimoxazole Tablets IP 480mg	MT404	01/2024	12/2026	Maxwell Lifescience Pvt Ltd, T-53 & T-81, M.I.D.C, Tarapur, Boisar, Dist, Palghar, 401506.	Sample does not conform to IP Specification for Co- Trimoxazole Tablets with respect to Dissolution for Sulphamethoxazole	Drugs Testing Laboratory, Chennai – 6
74.	Cipladine	CHO40018	01/2024	12/2025	HSN International, At point No.54-55,	Sample does not conform to USP	Drugs Testing Laboratory, Madurai –

					Sector 6A, I.IE, Sidcul Haridwar, (Uttarakhand), 249403	Specification for Povidone- Iodine Ointment with respect to the content of Avaible Iodine in Povidone Iodine,	19.
75.	Cipladine Ointment	CHO40020	01/2024	12/2025	HSN International, At point No.54-55, Sector 6A, I.IE, Sidcul Haridwar, (Uttarakhand), 249403	Sample does not conform to USP Specification for Povidone-Iodine Ointment with respect to the content of Avaible Iodine in Povidone Iodine.	Drugs Testing Laboratory, Madurai – 19.
76.	Atovaris-F	DEMT- 240124B	04/2024	03/2026	Dr.Edwin Medilabs Pvt Ltd, Plot No.B-29, Industrial Area, Focal Point, Chanalon, Kurali, SAS Nagar- 140103(pb).	Sample does not conform to IP Specification with respect to Uniformity of Weight.	Drugs Testing Laboratory, Madurai – 19.
77.	Capiwash Mouthwah	FL-050B	08/2023	07/2025	Forgo Pharmaceuticals, 27, Dic Ind Area, Barotiwala, the Baddi, Distt, Solan (H.P)- 174103	Sample does not conform to IP Specification for Chlorhexidine Mouthwash IP with respect to the content of Chlorhexidine Gluconate in Chlorhexidine Gluconate Solution.	Drugs Testing Laboratory, Madurai – 19.
78.	Povidone- Iodine Ointment USP	VG23017	11/2023	10/2025	Microwin Labs PVt Ltd, Plot No.363, Industrial Focal Point, Phase-9, Mohali- 160062.	Sample does not conform to USP Specification for Povidone – Iodine Ointment with	Drugs Testing Laboratory, Madurai – 19.

						respect to the content of Avaible Iodine in Povidone Iodine.
79.	Flucent Pour-on Solution	PB-105/12	12/2023	11/2025	Indo Gulf Pharmaceuticals, 5.4 K.M, Meerut Road, Muzaffarnagar (U.P)	Sample does not conform to Label claim with respect to Identification and Content of Flumethrin.	Drugs Testing Laboratory, Madurai – 19.
80.	Betamethasone Valerate Ointment IP 01% w/w	B06	05/2024	04/2026	Syndicate Pharma, 185/B, 185/B-1, 187/A & 188, sector -F, Sanwer Road, Indore- 452015.	Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.	Drugs Testing Laboratory, Madurai – 19.
81.	Clobium Suspension. Clobazam Oral Suspension BP 5mg	TYOL-047	07/2024	06/2026	Tanmed Pharma (I) Pvt Ltd, No.1/429, Multi Industrial Nagar, Gerugambakkam, Chennai-600128	Sample does not conform to BP specification for Clobazam Oral Suspension with respect to Dissolution and to the content of Clobazam	Drugs Testing Laboratory, Chennai- 6
82.	Chlorpheniramin e Maleate Injection	IAL77/23	12/2023	11/2025	Anra Pharamaceuticals Pvt Ltd, Madurai-Melur Road, Vellaripati, Madurai-625122	Sample does not conform to the requirement for Assay for Chlorpheniramine	King Institute of Preventive Medicine & Research, Guindy, Chennai-32
83.	Chro-B Gold	DCBGT- 2402	09/2024	02/2026	Kniss Laboratories (P) Ltd, Plot No. 9, Multe Industrial Estate,	Sample does not conform to label claim with respect to the content of	Drugs Testing Laboratory, Chennai – 6

Gerugambakkam,

Chennai – 600 128

Cholecalciferol

84.

Atorvastatin Tablets IP 10mg

A283

04/2024

03/2026

Rikenbik Pharma, 113, SIDCO Industrial Estate, Ambattur, Chennai-600098.

Sample does not conform to IP Specification for Atorvastatin Calcium Tablets

with respect to Dissolution.

Drugs Testing Laboratory, Chennai – 6

To view the official notice, click the link below:

https://medicaldialogues.in/pdf_upload/state-nsq-alert-for-the-month-of-dec-2024-2-271258.pdf

Powered by WPeMatico

Viewpoint: How the Health and Human Services secretary influences every aspect of America’s health

The secretary of the Department of Health and Human Services, or HHS, plays a significant role in every American’s access to health care and in the nation’s overall well-being.

Powered by WPeMatico

Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug for weight management.

Powered by WPeMatico

The obscure ‘quack’ who helped pioneer the modern clinical trial

Brighton and Sussex Medical School and Royal Sussex County Hospital researchers have published an analysis of Francis Hauksbee the Younger’s 1743 “Experimentum Crucis.” In the analysis, the researchers consider the systematic principles proposed by Hauksbee as an early contributor to future scientific medical trials.

Powered by WPeMatico

Experimental drug speeds up myelin repair, restoring vision in mice

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other neurological conditions that damage neurons.

Powered by WPeMatico

India probes mystery illness after 17 die: Reports

Authorities in India-administered Jammu and Kashmir were investigating a mysterious disease that has claimed the lives of 17 people, local media reports said Saturday.

Powered by WPeMatico

MP DME To start MSc Nursing, Post basic BSc Nursing Counselling 2024 tomorrow, check out Schedule

Madhya Pradesh- Madhya Pradesh Director of Medical Education (MPDME) is going to begin the MP State ANMTST, MSc Nursing, and post basic BSC Nursing Counselling for the academic year 2024. In this regard, MPDME has released the schedule for the candidates who are willing to take admission to the said nursing courses.

As per the schedule, the vacancy chart of MP State ANMTST, MSc Nursing and PBBSC Nursing Counselling 2024 has already been published on the official website of MPDME. Along with this, the online registration process by eligible candidates of 2024 ANMTST & MSc Nursing and PBBSC Nursing will start on 27 January 2025.

Also Read: MP DME Postpones NEET PG Round 2 Choice Filling

MP STATE ANMTST SCHEDULE

S.NO	EVENTS	DURATION	DAYS
1	Publication of vacancy chart.	26th January 2025	1 Day
2	Online Registration by eligible candidates of 2O24 ANMTST.	27 to 28 January 2025 (up to 11:59 PM)	2 Days
3	Publication of state Merit list of registered candidates.	29 January 2025	1 Day
4	Choice filling and locking by Mp Domicile registered candidates.	29 January 2025 up to 11:59 PM	1 Day
5	Provisional Allotment Result of First Round.	30th January 2025.	1 Day
6	Reporting & Admission at allotted college in person for document verifications and admission process.	31 January 2025 (up to 06:00 PM)	1 Day
7	online Resignation/cancellation of admission at a college level.	37 January 2025 up to 07:00 PM)	1 Day

MP STATE MSc AND PBBSC NURSING SCHEDULE

S.NO	EVENTS	DURATION	DAYS
1	Publication of vacancy chart.	26th January 2025	1 Day
2	Online Registration by eligible candidates of 2O24 MSc & PBBSc. Nursing.	27 January 2025 (up to 11:59 PM)	1 Day
3	Publication of state Merit list of registered candidates.	28th January 2025	1 Day
4	Choice filling and locking by Mp Domicile registered candidates.	28th January 2025 up to 11:59 PM	1 Day
5	Provisional Allotment Result of First Round.	30th January 2025.	1 Day
6	Reporting & Admission at allotted college in person for document verifications and admission process.	31 January 2025 (up to 06:00 PM)	1 Day
7	Online Resignation/cancellation of admission at a college level.	37 January 2025 up to 07:00 PM)	1 Day

To view the schedules, click the link below

https://medicaldialogues.in/pdf_upload/schedule-1-271123.pdf

https://medicaldialogues.in/pdf_upload/schedule-1-2-271122.pdf

Powered by WPeMatico

RGUHS Allows Pre-2019 MBBS Students to Opt for New Evaluation Scheme

Bengaluru- Following the complaints from students of the 2019-20 batch, the Rajiv Gandhi University of Health Sciences, RGUHS has decided to allow MBBS students enrolled before 2019-20 to choose the new scheme of evaluation with written consent.

MBBS students enrolled before 2019-20 had complained after they realised there was so much variation in the evaluation that one low mark out of the four options would result in a lower average. As per the evaluation pattern for students before the 2019-20 batch, each script was evaluated by four invigilators, and then the average was calculated. In case, if there is a 15% difference in marks between the evaluators, it was sent to the fifth evaluator.

Also Read: 1500 MBBS Seats To be Added in Karnataka

Meanwhile, as per the new scheme of evaluation, there will be only two evaluations and the best of the two will be considered for result calculation. However, there are no grace marks in the new system. Earlier, there were five grace marks. The passing criteria are a minimum of 40% in theory, 40% in practical and viva, and 50% in total of theory and practical. Each question paper will have MCQ questions of 10 marks, reports TOI.

In addition, the maximum period to complete the MBBS course is double the course duration, and in the new scheme, the first year has to be completed within four attempts/four years. On this, speaking to the TOI, a student said “While we welcome the decision of the university to give us a chance, our demand is to give us justice in the already completed exams. To write a new exam will need several lakhs of rupees in exam fees in some of the private medical colleges. There is a committee formed with student representatives to look into this issue”.

Further, the syndicate said that existing students of pre-2019 batches will be allowed to join the new scheme. The body has suggested taking a written undertaking from the students on a bond paper stating that they are ready to abide by the changes in the scheme, which will be forwarded by the respective college principals.

Also Read: Confusion over RGUHS PG Final Exam Eligibility Requirements! Doctors Seek Clarity from NMC

Powered by WPeMatico

NMC proposes changes in TEQ regulations- here’s how doctors, non-medical teachers react

New Delhi: One of the key changes introduced by the National Medical Commission (NMC) in the recently released Draft Teachers Eligibility Qualifications (TEQ) 2024 Regulations is to increase the pool of faculties to teach in medical colleges.

While on the one hand, NMC has allowed Diploma holders appointed as Senior Residents before 08.06.2017 of working as specialist/Medical Officers in a Government Medical College for six years to join the medical colleges as Assistant Professors, it has also specified that a non-teaching Consultant/Specialist/Medical Officer, possessing Postgraduate Medical Degree, working for at least four or ten years in a minimum 220 bedded teaching/non-teaching Government Hospitals shall also be eligible to become Assistant or Associate Professor respectively of that broad speciality.

Similarly, NMC has also specified that non-medical teachers can teach Anatomy, Biochemistry and Physiology provided that they have an MSc and PhD degree in that particular speciality.

However, the Commission has made it clear that the permission to allow non-medical teachers as faculties in medical colleges will only be given during the “transitional period” i.e. when there are not a sufficient number of qualified teaching faculties available for the respective subjects.

How do Doctors React?

A section of the medical fraternity has, however, expressed its objections to these proposed changes introduced by NMC, as few of them expressed their doubts that it might negatively affect the quality of medical education.

A contrarian view on the newly proposed TEQ 2024 Rules, was given by Dr. Kabir Sardana, a Professor of Dermatology at the Atal Bihari Vajpayee Institute of Medical Sciences and Ram Manohar Lohia Hospital, New Delhi, who told Medical Dialogues, that the new TEQ is “very backward-looking” and “incorrect”.

He said, “These regulations will kill research and just satisfy a magical number of so-called faculty who possibly did not attain the rank or merit to get an MD course or a faculty position. In fact when NMC stopped diploma it was as they realised this is achieving any high standards.Compare this with the West where faculty positions have a lot of emphasis on research and in India we are doing away with the most basic requirement, a thesis! It’s equivalent to a PhD in DU. How many DU faculty members have been appointed in 100 years without having even done a thesis, None!”

“But this is not to say that only a MD or a diploma is a good doctor, good clinicians are there across the spectrum, but a faculty position has to have some merit to it. How paradoxical that all other faculty even non teaching doctors have to have a MD or DNB ,but by some magical quality diplomas do not !” he further mentioned.

“It’s the end of merit and a high point of back door entry to satisfy a magical Doctor-patient ratio that is illogical as doctors don’t go to villages to practise,” he added.

Dr. Rohan Krishnan, the Chief patron of the Federation of All India Medical Association (FAIMA) has also strongly opposed NMC’s decision of “allowing diploma holders / non-medicos and almost anyone to teach MBBS students” as “hilarious”.

“It is so shameful that @MoHFW_INDIA is going to create an army of improperly trained MBBS doctors , who will be out of jobs. The situation of Dentists today is so bad that it makes me feel bad, lack of jobs, torture by corporates, Govt unable to help them!!!! All because fools and boot lickers sits on top of the seat of council and don’t guide the politicians properly!!!!” Dr. Krishnan mentioned in an X (formerly Twitter) post.

Speaking to Medical Dialogues in this regard, he added, “I think that it’s a regressive step taken by NMC. NMC is doing anything in its process of increasing the number of seats in the medical colleges. They are not bothered about the quality of medical education which is very sad. It is safe to say that NMC is in very bad hands and the entire process of giving seats to medical colleges stings of corruption.”

“Opening medical colleges, especially, private medical colleges, like this in the country is going to be catastrophic. What about the quality of education? What about the students who are going to get graduated? There will be a large number of doctors who are not qualified, who are not good for anything and later on they will suffer in terms of jobs and everything and the patients will also suffer,” he added.

Dr. Karan Juneja, the National Co-Convenor of the IMA Junior Doctors’ Network, has also expressed his concerns over these new rules, highlighting that “Quality of medical education is essential.”

Speaking to Medical Dialogues, Dr. Lakshya Mittal, the National President of United Doctors’ Front (UDF) opined that while addressing faculty shortages in the rapidly growing number of medical colleges is a necessity, this move should not come at the cost of compromising the quality of medical education.

“One of the key issues is the inclusion of non-medical teachers in foundational pre-clinical subjects like Anatomy, Biochemistry, and Physiology. These subjects form the backbone of medical education, and only those with a medical background can provide the necessary clinical perspective for teaching. While non-medical teachers may have expertise in their respective fields, they lack the clinical insight and interdisciplinary knowledge required for the Competency-Based Medical Education (CBME) curriculum, which emphasizes integrated learning and early clinical exposure,” Dr. Mittal said.

“Furthermore, the inclusion of diploma holders as faculty members raises questions about maintaining uniform academic standards. While diploma holders have practical expertise, the depth of knowledge and academic rigor of MD/MS programs is unmatched and critical for the teaching profession,” he further added.

Regarding the proposal to allow the non-teaching consultants or specialists with hospital experience to transition into academic roles as assistant or associate professors, he mentioned, “Although clinical experience is invaluable, teaching requires a distinct skill set that includes research acumen, effective communication, and the ability to guide students academically. A lack of formal teaching experience could hinder the quality of instruction provided to medical students.”

He also demanded clarity regarding the “transition period” and said, “It is imperative that the NMC specifies a defined timeline for these relaxations to prevent them from becoming permanent, especially in private medical institutions that may exploit such provisions to bypass the recruitment of highly qualified faculty.”

Dr. Indranil Deshmukh, the National Convener of IMA JDN has also opposed the inclusion of non-medical graduates as faculty members in medical colleges, as proposed in Draft TEQ 2024 Regulations. “This practice poses a serious threat to the quality of medical education and the future of healthcare standards in India. Teaching positions must be reserved exclusively for individuals with recognized medical qualifications to ensure the highest educational standards and the best outcomes for medical students and patients alike,” he said.

However, Dr. Aviral Mathur, the President of the Federation of Resident Doctors’ Association (FORDA), termed NMC’s decision to expand the faculty pool by including diploma holders and non-medical teachers as ‘creative’.

Dr. Mathur told Medical Dialogues, “While it’s clear that addressing faculty shortages is important, one has to wonder if diluting the expertise in our medical colleges is the best way to go about it. After all, medical education is a highly specialized field, and the idea of non-medical professionals teaching future doctors raises some interesting questions about the standards we aim to uphold.”

“If the goal is really to fill vacancies, a more sensible approach might be to focus on making specialized branches more appealing. Offering competitive salaries, career growth, and support for research could attract qualified professionals without compromising the quality of education. Reforms are necessary, but they should prioritize the integrity of our medical education, not just the speed at which we fill positions. After all, a well-trained doctor is the product of rigorous education, not a compromise on standards,” he added.

Meanwhile, the PG medical diploma holders, who have been fighting for their promotion for the last 7-8 years, have praised NMC for allowing them to join the medical colleges as faculties. Several of these PG medical diploma holders have been stuck in their positions as Senior Residents over the years without getting any promotion.

Earlier, speaking to Medical Dialogues, Dr. Z.A Golewale from PG Diploma Doctors Association had questioned why could Diploma holders, having years of experience in medical colleges, not be considered as medical college faculties when DNB students having no experience of working in a teaching hospital be considered for the same.

“We have been working as senior residents for years and are involved in teaching and clinical work and still they did not allow us as faculties. When you can rely on someone to treat the patient and you are risking the lives of the patients at their hands, then why restrict them in medical colleges?” he questioned.

Reactions from Non-Medical Teachers:

Non-medical teachers have, however, expressed their concerns and objections to the newly released Draft TEQ 2024 Regulations, especially regarding the criticism received from the medical fraternity and the NMC’s clarification that non-medical teachers would be allowed during the “transitional period” only.

Defining the “transition period”, NMC has mentioned in the Draft that in a speciality (subject) if enough faculty having qualifications of that speciality are not available, one with related qualifications and training/experience is made eligible to become faculty of that speciality for limited period till adequate number of faculty with qualification of such speciality are available. NMC has specified that this limited period is called a “transition period” and conditions required to be fulfilled for his will be called transition period criteria. The Commission has also mentioned that the duration of the transition period will be decided by NMC based on the recommendations by the Post Graduate Medical Educational Board (PGMEB).

Addressing the strong opposition expressed by the doctors against the NMC’s decision to include the non-medical teachers in the medical college faculty pool, the MSc Medicine Association mentioned in an X (formerly Twitter) post, “Even though we are trained and graduated from Medical Institutions, hold Medical Qualifications, practising for years, just because we came from non-MBBS backgrounds, they want to disqualify us, they want us to give away our practice, our years of investment of professional training and experience, hard earned qualifications, PG and PhD.”

The association also pointed out how the authorities did not listen to their concerns and prayers and added, “While NMC without any brain and empathy speaks of Transition Period to show us door to exit, there are around more than 30 plus Medical Institutions conducting MSc Medical Postgraduate courses as on today including @aiims_newdelhi @OfficialJipmer @RMLDelhi. Though we appealed to these institutions to take a stand on this issue in the interest of their alumni and the students pursuing these courses currently, appealed to the authorities including National Medical Commission, none felt the need or the responsibility to act upon this.”

Highlighting how the NMC’s decision to possibly barring the non-medical teachers to join medical colleges as faculties, the association further added, “What shall we do now? Those who qualified in Anatomy to teach MBBS students now should go to burial grounds and do practice? Those who are experts in Medical Biochemistry and Medical Microbiology qualified to teach MBBS, now should work in an unknown diagnostic lab in your area as a technician with 10 or 12k salary? Those Physiologists who are qualified to teach MBBS students, now should become a biology teacher and start conducting tuitions for school kids? For 100s or 1000s of monthly fee. You want us to start fresh? After investing our youth, potential years of a career and employment, and then to lose everything in Medical field and go out at these mid ages. Where do we start?”

The National M.Sc Medical Teachers’ Association (NMMTA) has also raised serious concerns over the recently proposed TEQ 2024 Regulations alleging that it threatens to “destabilize medical education in India and jeopardize the careers of thousands of experienced educators.”

“Introducing these TEQ guidelines at this stage may be inappropriate, given that the contentious issues are already under consideration by the Supreme Court,” the association further opined in a recent release.

NMMTA highlighted that for more than five decades, Medical M.Sc and Ph.D qualified professionals have been the backbone of medical educations in non-clinical subjects including Anatomy, Biochemistry, Physiology, Microbiology, and Pharmacology. It also pointed out that despite this contribution, the new regulations appear designed to systematically exclude these qualified professionals from the medical education.

Addressing the Draft Regulations, the association pointed out that the Draft discriminates qualification requirements as an additional Ph.D requirement has been imposed specifically on M.Sc qualified teachers. As per the association, this is creating unnecessary barriers, especially revealing the inequitable treatment despite M.Sc and MD being equivalent postgraduate qualifications.

Apart from this, the association has also opined that the undefined “transition period” is creating widespread uncertainty and potential displacement of currently employed teachers.

NMMTA has also called out the “Unjustified prohibition on non-medical persons heading departments” and disregarding the decades of teaching and administrative experience. As per the association, NMC has disregarded global standards also where non-medical faculty constitute up to 90% of medical teachers

Commenting on the matter, Dr. Arjun Maitra, NMMTA President mentioned in a release, “These regulations represent an unprecedented assault on the dignity and job security of thousands of qualified medical teachers.”

“While countries like the United States recognize and value our expertise, with non-medical qualified faculty forming the majority in their medical colleges, these regulations seek to eliminate our role entirely,” he added.

Also Read: Draft TEQ 2024: NMC Says Non-Medical Teachers Can Teach Anatomy, Biochemistry, Physiology, Doctors Cry Foul

Powered by WPeMatico

Telangana HC directs Govt to submit Detailed Report on vacant posts in hospitals

Hyderabad: The Telangana High Court has directed the State’s Health, Medical & Family Welfare Department to submit a comprehensive counter in response to a Public Interest Litigation (PIL) regarding the recruitment of medical and paramedical staff in government hospitals across the state.

A two-judge bench, led by Acting Chief Justice Sujoy Paul and Justice Dr. G. Radha Rani, took up the matter and instructed the authorities to provide a detailed response addressing several key issues raised by the petitioner.

Also Read: Rs 390 crore loss over expired drugs; Shortage of hospital beds, Staff: CAG Report flags health sector concerns in Telangana

The PIL highlights the failure of the authorities to comply with a Supreme Court ruling that mandates the establishment of district hospitals, Community Health Centres (CHCs), and Primary Health Centres (PHCs) across the state. The petitioner also raised concerns over the large number of vacant positions in existing government hospitals. Despite the growing need for medical staff in public healthcare facilities, the staff crisis remains constant.

As per the recent media report by The Siasat Daily, although the respondent authorities provided counters, the bench emphasized the need for a detailed response that thoroughly addresses all concerns raised in the PIL.

The Telangana High Court has now scheduled the matter for further hearing on February 20, urging the Health, Medical & Family Welfare Department to be prepared with a detailed report.

Also Read: Telangana High Court seeks Report on facilities at State-Run Hospitals

Medical dialogues had earlier reported that the Telangana High Court ordered a comprehensive report within a week on the facilities available in state-run hospitals across the state. The directive is followed by the PIL filed by Keethineedi Akhil Sri Guru Teja, president of “Help the People Charitable Trust”. In his PIL he expressed his concern about the lack of medical equipment. The court has directed the Government to provide necessary medical equipment including CT scanners and X-ray machines, telephone connections, blood banks, and the presence of a functional grievance mechanism in all government hospitals.

Powered by WPeMatico

84 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert

Viewpoint: How the Health and Human Services secretary influences every aspect of America’s health

Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks

The obscure ‘quack’ who helped pioneer the modern clinical trial

Experimental drug speeds up myelin repair, restoring vision in mice

India probes mystery illness after 17 die: Reports

MP DME To start MSc Nursing, Post basic BSc Nursing Counselling 2024 tomorrow, check out Schedule

RGUHS Allows Pre-2019 MBBS Students to Opt for New Evaluation Scheme

NMC proposes changes in TEQ regulations- here’s how doctors, non-medical teachers react

Telangana HC directs Govt to submit Detailed Report on vacant posts in hospitals

Find us @ Facebook

Search Anything

Archive for month: January, 2025

Find us @ Facebook

Find related topics

Search Anything